4
Changes in Ownership
Caribou Biosciences, Inc. Filed Acc 0001209191-22-007860
Chief Financial Officer acquired 24,336 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
O'Byrne Jason · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-08 | Exercise or conversion : show line 1 in the form | +24,336 | $4.11 | $100,021 | 24,336 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-08 | Exercise or conversion : show line 2 in the form Option to purchase Common Stock | −24,336 | 412,865 | D |
Loading xslF345X03/doc4.xml…